Alternatively activated microglia and macrophages in the central nervous system

Progress in Neurobiology

Volumn 131, Issue , 2015, Pages 65-86

  Franco, Rafael ^a,b   Fernández Suárez, Diana ^c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CIBERNED Centro Investigación Biomédica en Red Enfermedades Neurodegenerativas   (Spain)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cannabinoids; M1; M2; Neuroinflammation; Neuroprotection

Indexed keywords

CANNABINOID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STEROID HORMONE;

CELL CULTURE; CELL FUNCTION; CELL POLARITY; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; HUMAN; MACROPHAGE ACTIVATION; MICROGLIA; NEUROLOGIC DISEASE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; ANIMAL; CENTRAL NERVOUS SYSTEM DISEASE; MACROPHAGE; METABOLISM;

ANIMALS; CANNABINOIDS; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; MACROPHAGES; MICROGLIA; PHENOTYPE;

EID: 84938286568     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2015.05.003     Document Type: Review

References (383)

1. Ahrens R., Waddell A., Seidu L., Blanchard C., Carey R., Forbes E., Lampinen M., Wilson T., Cohen E., Stringer K., Ballard E., Munitz A., Xu H., Lee N., Lee J.J., Rothenberg M.E., Denson L., Hogan S.P. Intestinal macrophage/epithelial cell-derived CCL11/eotaxin-1 mediates eosinophil recruitment and function in pediatric ulcerative colitis. J. Immunol. 2008, 181:7390-7399.
2. Aisen P.S. The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease. Lancet Neurol. 2002, 1:279-284.
3. Ajami B., Bennett J.L., Krieger C., Tetzlaff W., Rossi F.M.V. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat. Neurosci. 2007, 10:1538-1543.
4. Ajmone-Cat M.A., Mancini M., De Simone R., Cilli P., Minghetti L. Microglial polarization and plasticity: evidence from organotypic hippocampal slice cultures. Glia 2013, 61:1698-1711.
5. Akimoto N., Honda K., Uta D., Beppu K., Ushijima Y., Matsuzaki Y., Nakashima S., Kido M.A., Imoto K., Takano Y., Noda M. CCL-1 in the spinal cord contributes to neuropathic pain induced by nerve injury. Cell Death Dis. 2013, 4:e679.
6. Akiyama H., McGeer P.L. Microglial response to 6-hydroxydopamine-induced substantia nigra lesions. Brain Res. 1989, 489:247-253.
7. Alboni S., Cervia D., Sugama S., Conti B. Interleukin 18 in the CNS. J. Neuroinflamm. 2010, 7:9.
8. Alexander H.R., Doherty G.M., Buresh C.M., Venzon D.J., Norton J.A. A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice. J. Exp. Med. 1991, 173:1029-1032.
9. Allahtavakoli M., Shabanzadeh A.P., Sadr S.S., Parviz M., Djahanguiri B. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, reduces infarction volume and neurological deficits in an embolic model of stroke. Clin. Exp. Pharmacol. Physiol. 2006, 33:1052-1058.
10. Allavena P., Sica A., Garlanda C., Mantovani A. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol. Rev. 2008, 222:155-161.
11. Alliot F., Marty M., Cambier D., Pessac B. A spontaneously immortalized mouse microglial cell line expressing CD4. Dev. Brain Res. 1996, 95:140-143.
12. Andersson A., Kokkola R., Wefer J., Erlandsson-Harris H., Harris R.A. Differential macrophage expression of IL-12 and IL-23 upon innate immune activation defines rat autoimmune susceptibility. J. Leukoc. Biol. 2004, 76:1118-1124.
13. Angulo E., Casadó V., Mallol J., Canela E.I., Viñals F., Ferrer I., Lluis C., Franco R. A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation. Brain Pathol. 2003, 13:440-451.
14. Bae K.R., Shim H.J., Balu D., Kim S.R., Yu S.W. Translocator protein 18kDa negatively regulates inflammation in microglia. J. Neuroimmune Pharmacol. 2014, 9:424-437.
15. Baker A.E., Brautigam V.M., Watters J.J. Estrogen modulates microglial inflammatory mediator production via interactions with estrogen receptor beta. Endocrinology 2004, 145:5021-5032.
16. Bala S., Marcos M., Kodys K., Csak T., Catalano D., Mandrekar P., Szabo G. Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor alpha production via increased mRNA half-life in alcoholic liver disease. J. Biol. Chem. 2011, 286:1436-1444.
17. Banati R.B., Gehrmann J., Schubert P., Kreutzberg G.W. Cytotoxicity of microglia. Glia 1993, 7:111-118.
18. Banati R.B., Kreutzberg G.W. Flow cytometry: measurement of proteolytic and cytotoxic activity of microglia. Clin. Neuropathol. 1993, 12:285-288.
19. Banisor I., Leist T.P., Kalman B. Involvement of beta-chemokines in the development of inflammatory demyelination. J. Neuroinflamm. 2005, 2:7.
20. Barondes S.H., Castronovo V., Cooper D.N., Cummings R.D., Drickamer K., Feizi T., Gitt M.A., Hirabayashi J., Hughes C., Kasai K. Galectins: a family of animal beta-galactoside-binding lectins. Cell 1994, 76:597-598.
21. Barron L., Wynn T.A. Macrophage activation governs schistosomiasis-induced inflammation and fibrosis. Eur. J. Immunol. 2011, 41:2509-2514.
22. Bazan J.F., Bacon K.B., Hardiman G., Wang W., Soo K., Rossi D., Greaves D.R., Zlotnik A., Schall T.J. A new class of membrane-bound chemokine with a CX3C motif. Nature 1997, 385:640-644.
23. Becher B., Durell B.G., Noelle R.J. IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis. J. Clin. Invest. 2003, 112:1186-1191.
24. Bedi S., Smith P., Hetz R., Xue H., Cox C. Immunomagnetic enrichment and flow cytometric characterization of mouse microglia. J. Neurosci. 2013, 219:176-182.
25. Bernardo A., Minghetti L. PPAR-gamma agonists as regulators of microglial activation and brain inflammation. Curr. Pharm. Des. 2006, 12:93-109.
26. Blain K.Y., Kwiatkowski W., Zhao Q., La Fleur D., Naik C., Chun T.-W., Tsareva T., Kanakaraj P., Laird M.W., Shah R., George L., Sanyal I., Moore P.A., Demeler B., Choe S. Structural and functional characterization of CC chemokine CCL14. Biochemistry 2007, 46:10008-10015.
27. Blakemore W.F. The ultrastructure of normal and reactive microglia. Acta Neuropathol. Suppl. 1975, 6:273-278.
28. Blasi E., Barluzzi R., Bocchini V., Mazzolla R., Bistoni F. Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J. Neuroimmunol. 1990, 27:229-237.
29. Block M.L., Hong J.-S. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog. Neurobiol. 2005, 76:77-98.
30. Block M.L., Zecca L., Hong J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 2007, 8:57-69.
31. Borda J.T., Alvarez X., Mohan M., Hasegawa A., Bernardino A., Jean S., Aye P., Lackner A.A. CD163, a marker of perivascular macrophages, is up-regulated by microglia in simian immunodeficiency virus encephalitis after haptoglobin-hemoglobin complex stimulation and is suggestive of breakdown of the blood-brain barrier. Am. J. Pathol. 2008, 172:725-737.
32. Bouchard C., Pagé J., Bédard A., Tremblay P., Vallières L. G protein-coupled receptor 84, a microglia-associated protein expressed in neuroinflammatory conditions. Glia 2007, 55:790-800.
33. Boza-Serrano A., Reyes J.F., Rey N.L., Leffler H., Bousset L., Nilsson U., Brundin P., Venero J.L., Burguillos M.A., Deierborg T. The role of Galectin-3 in alpha-synuclein-induced microglial activation. Acta Neuropathol. Commun. 2014, 2:156.
34. Brantley E.C., Guo L., Zhang C., Lin Q., Yokoi K., Langley R.R., Kruzel E., Maya M., Kim S.W.S.-J., Fan D., Fidler I.J. Nitric oxide-mediated tumoricidal activity of murine microglial cells. Transl. Oncol. 2010, 3:380-388.
35. Briers T.W., Desmaretz C., Vanmechelen E. Generation and characterization of mouse microglial cell lines. J. Neuroimmunol. 1994, 52:153-164.
36. Burguillos M.A., Svensson M., Schulte T., Boza-Serrano A., Garcia-Quintanilla A., Kavanagh E., Santiago M., Viceconte N., Oliva-Martin M.J., Osman A.M., Salomonsson E., Amar L., Persson A., Blomgren K., Achour A., Englund E., Leffler H., Venero J.L., Joseph B., Deierborg T. Microglia-secreted galectin-3 acts as a toll-like receptor 4 ligand and contributes to microglial activation. Cell Rep. 2015, 10.1016/j.celrep.2015.02.012.
37. Burke N.N., Kerr D.M., Moriarty O., Finn D.P., Roche M. Minocycline modulates neuropathic pain behaviour and cortical M1-M2 microglial gene expression in a rat model of depression. Brain. Behav. Immun. 2014, 147-156.
38. Bustos R., Sobrino F. Stimulation of glycolysis as an activation signal in rat peritoneal macrophages. Effect of glucocorticoids on this process. Biochem. J. 1992, 282(Pt 1):299-303.
39. Byers D.E., Holtzman M.J. Alternatively activated macrophages and airway disease. Chest 2011, 140:768-774.
40. Cagnin A., Brooks D.J., Kennedy A.M., Gunn R.N., Myers R., Turkheimer F.E., Jones T., Banati R.B. In-vivo measurement of activated microglia in dementia. Lancet 2001, 358:461-467.
41. Campanella M., Sciorati C., Tarozzo G., Beltramo M. Flow cytometric analysis of inflammatory cells in ischemic rat brain. Stroke 2002, 33:586-592.
42. Canton J., Neculai D., Grinstein S. Scavenger receptors in homeostasis and immunity. Nat. Rev. Immunol. 2013, 13:621-634.
43. Cardona A.E., Huang D., Sasse M.E., Ransohoff R.M. Isolation of murine microglial cells for RNA analysis or flow cytometry. Nat. Protoc. 2006, 1:1947-1951.
44. Cardona A.E., Pioro E.P., Sasse M.E., Kostenko V., Cardona S.M., Dijkstra I.M., Huang D., Kidd G., Dombrowski S., Dutta R., Lee J.-C., Cook D.N., Jung S., Lira S.A., Littman D.R., Ransohoff R.M. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 2006, 9:917-924.
45. Cardoso A.L., Guedes J.R., Pereira de Almeida L., Pedroso de Lima M.C. miR-155 modulates microglia-mediated immune response by down-regulating SOCS-1 and promoting cytokine and nitric oxide production. Immunology 2012, 135:73-88.
46. Carrillo-de Sauvage M.Á., Maatouk L., Arnoux I., Pasco M., Sanz Diez A., Delahaye M., Herrero M.T., Newman T.A., Calvo C.F., Audinat E., Tronche F., Vyas S. Potent and multiple regulatory actions of microglial glucocorticoid receptors during CNS inflammation. Cell Death Differ. 2013, 20:1546-1557.
47. Carter S.L., Müller M., Manders P.M., Campbell I.L. Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-gamma but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro. Glia 2007, 55:1728-1739.
48. Cassol E., Cassetta L., Alfano M., Poli G. Macrophage polarization and HIV-1 infection. J. Leukoc. Biol. 2010, 87:599-608.
49. Chaudhuri A.A., So A.Y.-L., Sinha N., Gibson W.S.J., Taganov K.D., O'Connell R.M., Baltimore D. MicroRNA-125b potentiates macrophage activation. J. Immunol. 2011, 187:5062-5068.
50. Cheepsunthorn P., Radov L., Menzies S., Reid J., Connor J.R. Characterization of a novel brain-derived microglial cell line isolated from neonatal rat brain. Glia 2001, 35:53-62.
51. Chen F., Wu W., Millman A., Craft J.F., Chen E., Patel N., Boucher J.L., Urban J.F., Kim C.C., Gause W.C. Neutrophils prime a long-lived effector macrophage phenotype that mediates accelerated Helminth expulsion. Nat. Immunol. 2014, 15:938-946.
52. Chen Z., Jalabi W., Hu W., Park H.-J., Gale J.T., Kidd G.J., Bernatowicz R., Gossman Z.C., Chen J.T., Dutta R., Trapp B.D. Microglial displacement of inhibitory synapses provides neuroprotection in the adult brain. Nat. Commun. 2014, 5:4486.
53. Chen Z., Jalabi W., Shpargel K.B., Farabaugh K.T., Dutta R., Yin X., Kidd G.J., Bergmann C.C., Stohlman S.A., Trapp B.D. Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4. J. Neurosci. 2012, 32:11706-11715.
54. Cherry J.D., Olschowka J.A., O'Banion M.K. Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J. Neuroinflamm. 2014, 11:98.
55. Cherry J.D., Olschowka J.A., O'Banion M.K. Are resting microglia more M2?. Front. Immunol. 2014, 5:2-5.
56. Cheung S.T., So E.Y., Chang D., Ming-Lum A., Mui A.L.-F. Interleukin-10 inhibits lipopolysaccharide induced miR-155 precursor stability and maturation. PLOS ONE 2013, 8:e71336.
57. Chhor V., Le Charpentier T., Lebon S., Oré M.-V., Celador I.L., Josserand J., Degos V., Jacotot E., Hagberg H., Sävman K., Mallard C., Gressens P., Fleiss B. Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro. Brain. Behav. Immun. 2013, 32:70-85. 10.1016/j.bbi.2013.02.005.
58. Chinetti-Gbaguidi G., Staels B. Macrophage polarization in metabolic disorders: functions and regulation. Curr. Opin. Lipidol. 2011, 22:365-372.
59. Chiu I.M., Morimoto E.T.A., Goodarzi H., Liao J.T., O'Keeffe S., Phatnani H.P., Muratet M., Carroll M.C., Levy S., Tavazoie S., Myers R.M., Maniatis T. A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep. 2013, 4:385-401.
60. Cicchetti F., Brownell A.L., Williams K., Chen Y.I., Livni E., Isacson O. Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging. Eur. J. Neurosci. 2002, 15:991-998.
61. Collino M., Aragno M., Mastrocola R., Gallicchio M., Rosa A.C., Dianzani C., Danni O., Thiemermann C., Fantozzi R. Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion. Eur. J. Pharmacol. 2006, 530:70-80.
62. Colton C.A. Heterogeneity of microglial activation in the innate immune response in the brain. J. Neuroimmune Pharmacol. 2009, 4:399-418.
63. Colton C.A., Mott R.T., Sharpe H., Xu Q., Van Nostrand W.E., Vitek M.P. Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J. Neuroinflamm. 2006, 3:27.
64. Columba-Cabezas S., Serafini B., Ambrosini E., Sanchez M., Penna G., Adorini L., Aloisi F. Induction of macrophage-derived chemokine/CCL22 expression in experimental autoimmune encephalomyelitis and cultured microglia: implications for disease regulation. J. Neuroimmunol. 2002, 130:10-21.
65. Combs C.K., Johnson D.E., Karlo J.C., Cannady S.B., Landreth G.E. Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists. J. Neurosci. 2000, 20:558-567.
66. Copeland S., Warren H.S., Lowry S.F., Calvano S.E., Remick D. Acute inflammatory response to endotoxin in mice and humans. Clin. Diagn. Lab. Immunol. 2005, 12:60-67.
67. Corraliza I.M., Soler G., Eichmann K., Modolell M. Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10 and PGE2) in murine bone-marrow-derived macrophages. Biochem. Biophys. Res. Commun. 1995, 206:667-673.
68. Crain J.M., Nikodemova M., Watters J.J. Microglia express distinct M1 and M2 phenotypic markers in the postnatal and adult central nervous system in male and female mice. J. Neurosci. Res. 2013, 91:1143-1151.
69. Croker B., Crozat K., Berger M., Xia Y., Sovath S., Schaffer L., Eleftherianos I., Imler J.-L., Beutler B. ATP-sensitive potassium channels mediate survival during infection in mammals and insects. Nat. Genet. 2007, 39:1453-1460.
70. Cuartero M.I., Ballesteros I., Moraga A., Nombela F., Vivancos J., Hamilton J.A., Corbí Á.L., Lizasoain I., Moro M.A. N2 neutrophils, novel players in brain inflammation after stroke: Modulation by the pparγ agonist rosiglitazone. Stroke 2013, 44:3498-3508.
71. Czapiga M., Colton C.A. Function of microglia in organotypic slice cultures. J. Neurosci. Res. 1999, 56:644-651.
72. Dailey M.E., Eyo U., Fuller L., Hass J., Kurpius D. Imaging microglia in brain slices and slice cultures. Cold Spring Harb. Protoc. 2013, 2013:1142-1148.
73. Dang J., Mitkari B., Kipp M., Beyer C. Gonadal steroids prevent cell damage and stimulate behavioral recovery after transient middle cerebral artery occlusion in male and female rats. Brain. Behav. Immun. 2011, 25:715-726.
74. Davalos D., Grutzendler J., Yang G., Kim J.V., Zuo Y., Jung S., Littman D.R., Dustin M.L., Gan W.-B. ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 2005, 8:752-758.
75. David S., Kroner A. Repertoire of microglial and macrophage responses after spinal cord injury. Nat. Rev. Neurosci. 2011, 12:388-399.
76. Del Rio-Hortega P. Studies on neuroglia: glia with very few processes (oligodendroglia) by Pío del Río-Hortega. 1921. Clin. Neuropathol. 2012, 31:440-459.
77. Delgado M. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the MEKK1/MEK4/JNK signaling pathway in endotoxin-activated microglia. Biochem. Biophys. Res. Commun. 2002, 293:771-776.
78. Delgado M. Inhibition of interferon (IFN) gamma-induced Jak-STAT1 activation in microglia by vasoactive intestinal peptide: inhibitory effect on CD40, IFN-induced protein-10, and inducible nitric-oxide synthase expression. J. Biol. Chem. 2003, 278:27620-27629.
79. Delgado M., Ganea D. Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson's disease by blocking microglial activation. FASEB J. 2003, 17:944-946.
80. Delgado M., Jonakait G.M., Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia. Glia 2002, 39:148-161.
81. Delgado M., Leceta J., Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microglia. J. Leukoc. Biol. 2003, 73:155-164.
82. Dentesano G., Serratosa J., Tusell J.M., Ramón P., Valente T., Saura J., Solà C. CD200R1 and CD200 expression are regulated by PPAR-γ in activated glial cells. Glia 2014, 62:982-998.
83. Desestret V., Riou A., Chauveau F., Cho T.-H., Devillard E., Marinescu M., Ferrera R., Rey C., Chanal M., Angoulvant D., Honnorat J., Nighoghossian N., Berthezène Y., Nataf S., Wiart M. In vitro and in vivo models of cerebral ischemia show discrepancy in therapeutic effects of M2 macrophages. PLOS ONE 2013, 8:e67063.
84. Djemadji-Oudjiel N., Goerdt S., Kodelja V., Schmuth M., Orfanos C.E. Immunohistochemical identification of type II alternatively activated dendritic macrophages (RM 3/1+3, MS-1+/-, 25F9-) in psoriatic dermis. Arch. Dermatol. Res. 1996, 288:757-764.
85. Doll D., Barr T., Simpkins J. Cytokines: their role in stroke and potential use as biomarkers and therapeutic targets. Aging Dis. 2014, 5:294-306.
86. Doorn K.J., Lucassen P.J., Boddeke H.W., Prins M., Berendse H.W., Drukarch B., van Dam A.-M. Emerging roles of microglial activation and non-motor symptoms in Parkinson's disease. Prog. Neurobiol. 2012, 98:222-238.
87. Dumitru C.D., Ceci J.D., Tsatsanis C., Kontoyiannis D., Stamatakis K., Lin J.H., Patriotis C., Jenkins N.A., Copeland N.G., Kollias G., Tsichlis P.N. TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 2000, 103:1071-1083.
88. Edison P., Ahmed I., Fan Z., Hinz R., Gelosa G., Ray Chaudhuri K., Walker Z., Turkheimer F.E., Brooks D.J. Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementia. Neuropsychopharmacology 2013, 38:938-949.
89. Ejlerskov P., Christensen D.P., Beyaie D., Burritt J.B., Paclet M.-H., Gorlach A., van Deurs B., Vilhardt F. NADPH oxidase is internalized by clathrin-coated pits and localizes to a Rab27A/B GTPase-regulated secretory compartment in activated macrophages. J. Biol. Chem. 2012, 287:4835-4852.
90. Enestvedt C.K., Hosack L., Winn S.R., Diggs B.S., Uchida B., O'Rourke R.W., Jobe B.A. VEGF gene therapy augments localized angiogenesis and promotes anastomotic wound healing: a pilot study in a clinically relevant animal model. J. Gastrointest. Surg. 2008, 12:1762-1770. discussion 1771-1772.
91. Esen N., Blakely P.K., Rainey-Barger E.K., Irani D.N. Complexity of the microglial activation pathways that drive innate host responses during lethal alphavirus encephalitis in mice. ASN Neuro 2012, 4:207-221.
92. Esen N., Rainey-Barger E.K., Huber A.K., Blakely P.K., Irani D.N. Type-I interferons suppress microglial production of the lymphoid chemokine, CXCL13. Glia 2014, 62:1452-1462.
93. Esiri M.M., Booss J. Comparison of methods to identify microglial cells and macrophages in the human central nervous system. J. Clin. Pathol. 1984, 37:150-156.
94. Espinoza-Jiménez A., Peón A.N., Terrazas L.I. Alternatively activated macrophages in types 1 and 2 diabetes. Mediators Inflamm. 2012, 2012:815953.
95. Evans B.J., Haskard D.O., Sempowksi G., Landis R.C. Evolution of the macrophage CD163 phenotype and cytokine profiles in a human model of resolving inflammation. Int. J. Inflamm. 2013, 2013:780502.
96. Fenn A.M., Henry C.J., Huang Y., Dugan A., Godbout J.P. Lipopolysaccharide-induced interleukin (IL)-4 receptor-α expression and corresponding sensitivity to the M2 promoting effects of IL-4 are impaired in microglia of aged mice. Brain. Behav. Immun. 2012, 26:766-777.
97. Fernandez E.J., Lolis E. Structure, function, and inhibition of chemokines. Annu. Rev. Pharmacol. Toxicol. 2002, 42:469-499.
98. Fernández-Suárez D., Celorrio M., Riezu-Boj J.I., Ugarte A., Pacheco R., González H., Oyarzabal J., Hillard C.J., Franco R., Aymerich M.S. The monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model. Neurobiol. Aging 2014, 35:2603-2616.
99. Ferrante C.J., Leibovich S.J. Regulation of macrophage polarization and wound healing. Adv. Wound Care 2012, 1:10-16.
100. Ferrante C.J., Pinhal-Enfield G., Elson G., Cronstein B.N., Hasko G., Outram S., Leibovich S.J. The adenosine-dependent angiogenic switch of macrophages to an M2-like phenotype is independent of interleukin-4 receptor alpha (IL-4Rα) signaling. Inflammation 2013, 36:921-931.
101. Ferrer I., Sarmiento J. Nascent microglia in the developing brain. Acta Neuropathol. 1980, 50:61-67.
102. Filipovic R., Jakovcevski I., Zecevic N. GRO-alpha and CXCR2 in the human fetal brain and multiple sclerosis lesions. Dev. Neurosci. 2003, 25:279-290.
103. Ford A.L., Goodsall A.L., Hickey W.F., Sedgwick J.D. Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared. J. Immunol. 1995, 154:4309-4321.
104. Freilich R.W., Woodbury M.E., Ikezu T. Integrated expression profiles of mRNA and miRNA in polarized primary murine microglia. PLOS ONE 2013, 8:e79416.
105. Fumagalli S., Perego C., Ortolano F., De Simoni M.-G. CX3CR1 deficiency induces an early protective inflammatory environment in ischemic mice. Glia 2013, 61:827-842.
106. Gagne J.J., Power M.C. Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis. Neurology 2010, 74:995-1002.
107. Galván-Peña S., O'Neill L.A.J. Metabolic reprogramming in macrophage polarization. Front. Immunol. 2014, 5:1-6.
108. Gao H.M., Liu B., Zhang W., Hong J.S. Novel anti-inflammatory therapy for Parkinson's disease. Trends Pharmacol. Sci. 2003, 24:395-401.
109. Gao M., Wang M., Miller K.D., Hutchins G.D., Zheng Q.H. Synthesis and in vitro biological evaluation of carbon-11-labeled quinoline derivatives as new candidate PET radioligands for cannabinoid CB2 receptor imaging. Bioorg. Med. Chem. 2010, 18:2099-2106.
110. Gao X., Chen H., Schwarzschild M.A., Ascherio A. Use of ibuprofen and risk of Parkinson disease. Neurology 2011, 76:863-869.
111. Garmire L.X., Shen Z., Briggs S., Yeo G., Subramaniam S., Glass C. Regulatory network of microRNAs in RAW 264.7 macrophage cells. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2010, 2010:6198-6201.
112. Gautier E.L., Shay T., Miller J., Greter M., Jakubzick C., Ivanov S., Helft J., Chow A., Elpek K.G., Gordonov S., Mazloom A.R., Ma'ayan A., Chua W.-J., Hansen T.H., Turley S.J., Merad M., Randolph G.J. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat. Immunol. 2012, 13:1118-1128.
113. Gerhard A., Banati R.B., Goerres G.B., Cagnin A., Myers R., Gunn R.N., Turkheimer F., Good C.D., Mathias C.J., Quinn N., Schwarz J., Brooks D.J. [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy. Neurology 2003, 61:686-689.
114. Gibbons H.M., Dragunow M. Adult human brain cell culture for neuroscience research. Int. J. Biochem. Cell Biol. 2010, 42:844-856.
115. Ginhoux F., Greter M., Leboeuf M., Nandi S., See P., Gokhan S., Mehler M.F., Conway S.J., Ng L.G., Stanley E.R., Samokhvalov I.M., Merad M. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010, 330:841-845.
116. Ginhoux F., Jung S. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat. Rev. Immunol. 2014, 14:392-404.
117. Girard S., Brough D., Lopez-Castejon G., Giles J., Rothwell N.J., Allan S.M. Microglia and macrophages differentially modulate cell death after brain injury caused by oxygen-glucose deprivation in organotypic brain slices. Glia 2013, 61:813-824.
118. Girard S., Larouche A., Kadhim H., Rola-Pleszczynski M., Gobeil F., Sébire G. Lipopolysaccharide and hypoxia/ischemia induced IL-2 expression by microglia in neonatal brain. Neuroreport 2008, 19:997-1002.
119. Glezer I., Zekki H., Scavone C., Rivest S. Modulation of the innate immune response by NMDA receptors has neuropathological consequences. J. Neurosci. 2003, 23:11094-11103.
120. Godbout J.P., Chen J., Abraham J., Richwine A.F., Berg B.M., Kelley K.W., Johnson R.W. Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. FASEB J. 2005, 19:1329-1331.
121. Gomez-Nicola D., Valle-Argos B., Nieto-Sampedro M. Blockade of IL-15 activity inhibits microglial activation through the NFkappaB, p38, and ERK1/2 pathways, reducing cytokine and chemokine release. Glia 2010, 58:264-276.
122. Gonzalez-Rey E., Delgado M. Vasoactive intestinal peptide inhibits cyclooxygenase-2 expression in activated macrophages, microglia, and dendritic cells. Brain. Behav. Immun. 2008, 22:35-41.
123. Gresa-Arribas N., Viéitez C., Dentesano G., Serratosa J., Saura J., Solà C. Modelling neuroinflammation in vitro: a tool to test the potential neuroprotective effect of anti-inflammatory agents. PLoS ONE 2012, 7:e45227.
124. Guadagno J., Xu X., Karajgikar M., Brown A., Cregan S.P. Microglia-derived TNFα induces apoptosis in neural precursor cells via transcriptional activation of the Bcl-2 family member Puma. Cell Death Dis. 2013, 4:e538.
125. Guedes J.R., Custódia C.M., Silva R.J., de Almeida L.P., Pedroso de Lima M.C., Cardoso A.L. Early miR-155 upregulation contributes to neuroinflammation in Alzheimer's disease triple transgenic mouse model. Hum. Mol. Genet. 2014, 23:6286-6301.
126. Habib P., Beyer C. Regulation of brain microglia by female gonadal steroids. J. Steroid Biochem. Mol. Biol. 2014, 47-48.
127. Habib P., Dreymueller D., Ludwig A., Beyer C., Dang J. Sex steroid hormone-mediated functional regulation of microglia-like BV-2 cells during hypoxia. J. Steroid Biochem. Mol. Biol. 2013, 138:195-205.
128. Habib P., Slowik A., Zendedel A., Johann S., Dang J., Beyer C. Regulation of hypoxia-induced inflammatory responses and M1-M2 phenotype switch of primary rat microglia by Sex steroids. J. Mol. Neurosci. 2014, 52:277-285.
129. Han Z., Li L., Wang L., Degos V., Maze M., Su H. Alpha-7 nicotinic acetylcholine receptor agonist treatment reduces neuroinflammation, oxidative stress, and brain injury in mice with ischemic stroke and bone fracture. J. Neurochem. 2014, 1-11.
130. Han Z., Shen F., He Y., Degos V., Camus M., Maze M., Young W.L., Su H. Activation of α-7 nicotinic acetylcholine receptor reduces ischemic stroke injury through reduction of pro-inflammatory macrophages and oxidative stress. PLOS ONE 2014, 9:e105711.
131. Hanisch U.-K. Functional diversity of microglia - how heterogeneous are they to begin with?. Front. Cell. Neurosci. 2013, 7:65-70.
132. Harms A.S., Cao S., Rowse A.L., Thome A.D., Li X., Mangieri L.R., Cron R.Q., Shacka J.J., Raman C., Standaert D.G. MHCII is required for α-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration. J. Neurosci. 2013, 33:9592-9600.
133. Harrison J.K., Jiang Y., Chen S., Xia Y., Maciejewski D., McNamara R.K., Streit W.J., Salafranca M.N., Adhikari S., Thompson D.A., Botti P., Bacon K.B., Feng L. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:10896-10901.
134. Hassan S., Eldeeb K., Millns P.J., Bennett A.J., Alexander S.P.H., Kendall D.A. Cannabidiol enhances microglial phagocytosis via transient receptor potential (TRP) channel activation. Br. J. Pharmacol. 2014, 171:2426-2439.
135. Hayes G.M., Woodroofe M.N., Cuzner M.L. Characterisation of microglia isolated from adult human and rat brain. J. Neuroimmunol. 1988, 19:177-189.
136. Heilbronn L.K., Campbell L.V. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Curr. Pharm. Des. 2008, 14:1225-1230.
137. Henn A., Lund S., Hedtjarn M. The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. ALTEX 2009, 83-94.
138. Henry C.J., Huang Y., Wynne A.M., Godbout J.P. Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1beta and anti-inflammatory IL-10 cytokines. Brain. Behav. Immun. 2009, 23:309-317.
139. Hide I., Tanaka M., Inoue A., Nakajima K., Kohsaka S., Inoue K., Nakata Y. Extracellular ATP triggers tumor necrosis factor-alpha release from rat microglia. J. Neurochem. 2000, 75:965-972.
140. Hines D.J., Choi H.B., Hines R.M., Phillips A.G., MacVicar B.A. Prevention of LPS-induced microglia activation, cytokine production and sickness behavior with TLR4 receptor interfering peptides. PLOS ONE 2013, 8:e60388.
141. Hines D.J., Hines R.M., Mulligan S.J., Macvicar B.A. Microglia processes block the spread of damage in the brain and require functional chloride channels. Glia 2009, 57:1610-1618. 10.1002/glia.20874.
142. Hirai T., Uchida K., Nakajima H., Guerrero A.R., Takeura N., Watanabe S., Sugita D., Yoshida A., Johnson W.E.B., Baba H. The prevalence and phenotype of activated microglia/macrophages within the spinal cord of the hyperostotic mouse (twy/twy) changes in response to chronic progressive spinal cord compression: implications for human cervical compressive myelopathy. PLOS ONE 2013, 8:e64528.
143. Hu X., Li P., Guo Y., Wang H., Leak R., Chen S. Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke 2012, 43:3063-3070.
144. Huang B.-R., Chang P.-C., Yeh W.-L., Lee C.-H., Tsai C.-F., Lin C., Lin H.-Y., Liu Y.-S., Wu C.Y.-J., Ko P.-Y., Huang S.-S., Hsu H.-C., Lu D.-Y. Anti-neuroinflammatory effects of the calcium channel blocker nicardipine on microglial cells: implications for neuroprotection. PLOS ONE 2014, 9:e91167.
145. Huang H., Liu T., Rose J.L., Stevens R.L., Hoyt D.G. Sensitivity of mice to lipopolysaccharide is increased by a high saturated fat and cholesterol diet. J. Inflamm. (Lond.) 2007, 4:22.
146. Iglesias-Rozas J.R., Garrosa M. The discovery of oligodendroglia cells by Rio-Hortega: his original articles, 1921. Clin. Neuropathol. 2012, 31:437-439.
147. Imamura K., Hishikawa N., Sawada M., Nagatsu T., Yoshida M., Hashizume Y. Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains. Acta Neuropathol. 2003, 106:518-526.
148. Jadhav S.P., Kamath S.P., Choolani M., Lu J., Dheen S.T. microRNA-200b modulates microglia-mediated neuroinflammation via the cJun/MAPK pathway. J. Neurochem. 2014, 130:388-401.
149. Jaguin M., Houlbert N., Fardel O., Lecureur V. Polarization profiles of human M-CSF-generated macrophages and comparison of M1-markers in classically activated macrophages from GM-CSF and M-CSF origin. Cell. Immunol. 2013, 281:51-61.
150. Janabi N., Peudenier S., Héron B., Ng K., Tardieu M. Establishment of human microglial cell lines after transfection of primary cultures of embryonic microglial cells with the SV40 large T antigen. Neurosci. Lett. 1995, 195:105-108.
151. Jaturapatporn D., Isaac M.G.E.K.N., McCleery J., Tabet N. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease. Cochrane database Syst. Rev. 2012, 2:CD006378.
152. Jeannin P., Duluc D., Delneste Y. IL-6 and leukemia-inhibitory factor are involved in the generation of tumor-associated macrophage: regulation by IFN-γ. Immunotherapy 2011, 3:23-26.
153. Jiang M.H., Chung E., Chi G.F., Ahn W., Lim J.E., Hong H.S., Kim D.W., Choi H., Kim J., Son Y. Substance P induces M2-type macrophages after spinal cord injury. Neuroreport 2012, 23:786-792.
154. Jin Q., Cheng J., Liu Y., Wu J., Wang X., Wei S., Zhou X., Qin Z., Jia J., Zhen X. Improvement of functional recovery by chronic metformin treatment is associated with enhanced alternative activation of microglia/macrophages and increased angiogenesis and neurogenesis following experimental stroke. Brain. Behav. Immun. 2014, 40:131-142.
155. Joseph B., Venero J. Microglia: Methods and Protocols 2013.
156. Juknat A., Pietr M., Kozela E., Rimmerman N., Levy R., Gao F., Coppola G., Geschwind D., Vogel Z. Microarray and pathway analysis reveal distinct mechanisms underlying cannabinoid-mediated modulation of LPS-induced activation of BV-2 microglial cells. PLOS ONE 2013, 8:e61462.
157. Jung S., Aliberti J., Graemmel P., Sunshine M.J., Kreutzberg G.W., Sher A., Littman D.R. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 2000, 20:4106-4114.
158. Jurcovicova J. Glucose transport in brain - effect of inflammation. Endocr. Regul. 2014, 48:35-48.
159. Kanzawa T., Sawada M., Kato K., Yamamoto K., Mori H., Tanaka R. Differentiated regulation of allo-antigen presentation by different types of murine microglial cell lines. J. Neurosci. Res. 2000, 62:383-388.
160. Kawahara K., Gotoh T., Oyadomari S., Kuniyasu A., Kohsaka S., Mori M., Nakayama H. Nitric oxide inhibits the proliferation of murine microglial MG5 cells by a mechanism involving p21 but independent of p53 and cyclic guanosine monophosphate. Neurosci. Lett. 2001, 310:89-92.
161. Kawahara K., Suenobu M., Yoshida A., Koga K., Hyodo A., Ohtsuka H., Kuniyasu A., Tamamaki N., Sugimoto Y., Nakayama H. Intracerebral microinjection of interleukin-4/interleukin-13 reduces β-amyloid accumulation in the ipsilateral side and improves cognitive deficits in young amyloid precursor protein 23 mice. Neuroscience 2012, 207:243-260.
162. Kawanokuchi J., Mizuno T., Takeuchi H., Kato H., Wang J., Mitsuma N., Suzumura A. Production of interferon-gamma by microglia. Mult. Scler. 2006, 12:558-564.
163. Kawanokuchi J., Shimizu K., Nitta A., Yamada K., Mizuno T., Takeuchi H., Suzumura A. Production and functions of IL-17 in microglia. J. Neuroimmunol. 2008, 194:54-61.
164. Kennard J., Zolla-Pazner S. Origin and function of suppressor macrophages in myeloma. J. Immunol. 1980, 124:268-273.
165. Kim K.-W., Vallon-Eberhard A., Zigmond E., Farache J., Shezen E., Shakhar G., Ludwig A., Lira S.A., Jung S. In vivo structure/function and expression analysis of the CX3C chemokine fractalkine. Blood 2011, 118:e156-e167.
166. Kim Y.-J., Hwang S.-Y., Oh E.-S., Oh S., Han I.-O. IL-1beta, an immediate early protein secreted by activated microglia, induces iNOS/NO in C6 astrocytoma cells through p38 MAPK and NF-kappaB pathways. J. Neurosci. Res. 2006, 84:1037-1046.
167. Kipp M., Berger K., Clarner T., Dang J., Beyer C. Sex steroids control neuroinflammatory processes in the brain: relevance for acute ischaemia and degenerative demyelination. J. Neuroendocrinol. 2012, 24:62-70.
168. Kline A.E., Bolinger B.D., Kochanek P.M., Carlos T.M., Yan H.Q., Jenkins L.W., Marion D.W., Dixon C.E. Acute systemic administration of interleukin-10 suppresses the beneficial effects of moderate hypothermia following traumatic brain injury in rats. Brain Res. 2002, 937:22-31.
169. Kodelja V., Müller C., Politz O., Hakij N., Orfanos C.E., Goerdt S. Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. J. Immunol. 1998, 160:1411-1418.
170. Kodelja V., Müller C., Tenorio S., Schebesch C., Orfanos C.E., Goerdt S. Differences in angiogenic potential of classically vs alternatively activated macrophages. Immunobiology 1997, 197:478-493.
171. Komohara Y., Ohnishi K. Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J. Pathol. 2008, 216:15-24.
172. Konat G.W., Kielian T., Marriott I. The role of Toll-like receptors in CNS response to microbial challenge. J. Neurochem. 2006, 99:1-12.
173. Kong W., Li H., Tuma R.F., Ganea D. Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS. Cell. Immunol. 2014, 287:1-17.
174. Kozlowski C., Weimer R.M. An automated method to quantify microglia morphology and application to monitor activation state longitudinally in vivo. PLoS ONE 2012, 7:e31814.
175. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 1996, 19:312-318.
176. Kroner A., Greenhalgh A.D., Zarruk J.G., Passos dos Santos R., Gaestel M., David S. TNF and increased intracellular iron alter macrophage polarization to a detrimental M1 phenotype in the injured spinal cord. Neuron 2014, 83:1098-1116.
177. Kuno R., Wang J., Kawanokuchi J., Takeuchi H., Mizuno T., Suzumura A. Autocrine activation of microglia by tumor necrosis factor-alpha. J. Neuroimmunol. 2005, 162:89-96.
178. La Flamme A.C., Kharkrang M., Stone S., Mirmoeini S., Chuluundorj D., Kyle R. Type II-activated murine macrophages produce IL-4. PLoS ONE 2012, 7:e46989.
179. Laing K.J., Secombes C.J. Chemokines. Dev. Comp. Immunol. 2004, 28:443-460.
180. Lammertse D.P., Jones L.A.T., Charlifue S.B., Kirshblum S.C., Apple D.F., Ragnarsson K.T., Falci S.P., Heary R.F., Choudhri T.F., Jenkins A.L., Betz R.R., Poonian D., Cuthbert J.P., Jha A., Snyder D.A., Knoller N. Autologous incubated macrophage therapy in acute, complete spinal cord injury: results of the phase 2 randomized controlled multicenter trial. Spinal Cord 2012, 50:661-671.
181. Lanciego J.L., Barroso-Chinea P., Rico A.J., Conte-Perales L., Callén L., Roda E., Gómez-Bautista V., López I.P., Lluis C., Labandeira-García J.L., Franco R. Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis. J. Psychopharmacol. 2011, 25:97-104.
182. Lapaque N., Walzer T., Meresse S., Vivier E., Trowsdale J. Interactions between human NK cells and macrophages in response to Salmonella infection. J. Immunol. 2009, 182:4339-4348.
183. Lassmann H. The birth of oligodendrocytes in the anatomical and neuropathological literature: the seminal contribution of Pio del Rio-Hortega, 1921. Clin. Neuropathol. 2012, 31:435-436.
184. Lee J.-S., Kim I.S. Leukotactin-1/CCL15 induces cell migration and differentiation of human eosinophilic leukemia EoL-1 cells through PKCdelta activation. Mol. Biol. Rep. 2010, 37:2149-2156.
185. Leffler H., Carlsson S., Hedlund M., Qian Y., Poirier F. Introduction to galectins. Glycoconj. J. 2004, 19:433-440.
186. Lei B., Mace B., Dawson H.N., Warner D.S., Laskowitz D.T., James M.L. Anti-inflammatory effects of progesterone in lipopolysaccharide-stimulated BV-2 microglia. PLOS ONE 2014, 9:e103969.
187. Lerman B.J., Hoffman E.P., Sutherland M.L., Bouri K., Hsu D.K., Liu F.-T., Rothstein J.D., Knoblach S.M. Deletion of galectin-3 exacerbates microglial activation and accelerates disease progression and demise in a SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Brain Behav. 2012, 2:563-575.
188. Li M.O., Wan Y.Y., Sanjabi S., Robertson A.-K.L., Flavell R.A. Transforming growth factor-beta regulation of immune responses. Annu. Rev. Immunol. 2006, 24:99-146.
189. Lindberg C., Crisby M., Winblad B., Schultzberg M. Effects of statins on microglia. J. Neurosci. Res. 2005, 82:10-19.
190. Liongue C., Ward A.C. Evolution of Class I cytokine receptors. BMC Evol. Biol. 2007, 7:120.
191. Liu B.-S., Ferreira R., Lively S., Schlichter L.C. Microglial SK3 and SK4 currents and activation state are modulated by the neuroprotective drug, riluzole. J. Neuroimmune Pharmacol. 2013, 8:227-237.
192. Liu H.-C., Zheng M.-H., Du Y.-L., Wang L., Kuang F., Qin H.-Y., Zhang B.-F., Han H. N9 microglial cells polarized by LPS and IL4 show differential responses to secondary environmental stimuli. Cell. Immunol. 2012, 278:84-90.
193. Liu P.-S., Lin Y.-W., Lee B., McCrady-Spitzer S.K., Levine J.A., Wei L.-N. Reducing RIP140 expression in macrophage alters ATM infiltration, facilitates white adipose tissue browning, and prevents high-fat diet-induced insulin resistance. Diabetes 2014, 63:4021-4031.
194. Loke P., MacDonald A.S., Robb A., Maizels R.M., Allen J.E. Alternatively activated macrophages induced by nematode infection inhibit proliferation via cell-to-cell contact. Eur. J. Immunol. 2000, 30:2669-2678.
195. Loram L.C., Sholar P.W., Taylor F.R., Wiesler J.L., Babb J.A., Strand K.A., Berkelhammer D., Day H.E.W., Maier S.F., Watkins L.R. Sex and estradiol influence glial pro-inflammatory responses to lipopolysaccharide in rats. Psychoneuroendocrinology 2012, 37:1688-1699.
196. Louafi F., Martinez-Nunez R.T., Sanchez-Elsner T. MicroRNA-155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-{beta}. J. Biol. Chem. 2010, 285:41328-41336.
197. Lourbopoulos A., Grigoriadis N., Lagoudaki R., Touloumi O., Polyzoidou E., Mavromatis I., Tascos N., Breuer A., Ovadia H., Karussis D., Shohami E., Mechoulam R., Simeonidou C. Administration of 2-arachidonoylglycerol ameliorates both acute and chronic experimental autoimmune encephalomyelitis. Brain Res. 2011, 1390:126-141.
198. Maeda J., Higuchi M., Inaji M., Ji B., Haneda E., Okauchi T., Zhang M.-R., Suzuki K., Suhara T. Phase-dependent roles of reactive microglia and astrocytes in nervous system injury as delineated by imaging of peripheral benzodiazepine receptor. Brain Res. 2007, 1157:100-111.
199. Mahdavian Delavary B., van der Veer W.M., van Egmond M., Niessen F.B., Beelen R.H.J. Macrophages in skin injury and repair. Immunobiology 2011, 216:753-762.
200. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004, 25:677-686.
201. Mantovani A., Sozzani S., Locati M., Allavena P., Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002, 23:549-555.
202. Maresz K., Carrier E.J., Ponomarev E.D., Hillard C.J., Dittel B.N. Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli. J. Neurochem. 2005, 95:437-445.
203. Martich G.D., Danner R.L., Ceska M., Suffredini A.F. Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents. J. Exp. Med. 1991, 173:1021-1024.
204. Martinez F.O., Helming L., Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol. 2009, 27:451-483.
205. Martinez F.O., Sica A., Mantovani A., Locati M. Macrophage activation and polarization. Front. Biosci. 2008, 13:453-461.
206. Martinez-Nunez R.T., Louafi F., Sanchez-Elsner T. The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1 (IL13Ralpha1). J. Biol. Chem. 2011, 286:1786-1794.
207. Mathison J.C., Wolfson E., Ulevitch R.J. Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. J. Clin. Invest. 1988, 81:1925-1937.
208. Matsuzaki J., Kuwamura M., Yamaji R., Inui H., Nakano Y. Inflammatory responses to lipopolysaccharide are suppressed in 40% energy-restricted mice. J. Nutr. 2001, 131:2139-2144.
209. Matthews M.A. Microglia and reactive M cells of degenerating central nervous system: does similar morphology and function imply a common origin?. Cell Tissue Res. 1974, 148:477-491.
210. Matthews M.A., Kruger L. Electron microscopy of non-neuronal cellular changes accompanying neural degeneration in thalamic nuclei of the rabbit. I. Reactive hematogenous and perivascular elements within the basal lamina. J. Comp. Neurol. 1973, 148:285-312.
211. Matthews M.A., Kruger L. Electron microscopy of non-neuronal cellular changes accompanying neural degeneration in thalamic nuclei of the rabbit. II. Reactive elements within the neuropil. J. Comp. Neurol. 1973, 148:313-346.
212. McGeer P.L., Itagaki S., McGeer E.G. Expression of the histocompatibility glycoprotein HLA-DR in neurological disease. Acta Neuropathol. 1988, 76:550-557.
213. McGeer P.L., Itagaki S., Tago H., McGeer E.G. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci. Lett. 1987, 79:195-200.
214. McGeer P.L., McGeer E.G. Inflammation and neurodegeneration in Parkinson's disease. Parkinsonism Relat. Disord. 2004, 10(Suppl. 1):S3-S7.
215. McGeer P.L., McGeer E.G. Glial reactions in Parkinson's disease. Mov. Disord. 2008, 23:474-483.
216. Mecha M., Feliú A., Iñigo P.M., Mestre L., Carrillo-Salinas F.J., Guaza C. Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors. Neurobiol. Dis. 2013, 59:141-150.
217. Mège J.-L., Mehraj V., Capo C. Macrophage polarization and bacterial infections. Curr. Opin. Infect. Dis. 2011, 24:230-234.
218. Melief J., Koning N., Schuurman K.G., Van De Garde M.D.B., Smolders J., Hoek R.M., Van Eijk M., Hamann J., Huitinga I. Phenotyping primary human microglia: tight regulation of LPS responsiveness. Glia 2012, 60:1506-1517.
219. Mélik-Parsadaniantz S., Rostène W. Chemokines and neuromodulation. J. Neuroimmunol. 2008, 198:62-68.
220. Michelucci A., Heurtaux T., Grandbarbe L., Morga E., Heuschling P. Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: effects of oligomeric and fibrillar amyloid-beta. J. Neuroimmunol. 2009, 210:3-12.
221. Michie H.R., Manogue K.R., Spriggs D.R., Revhaug A., O'Dwyer S., Dinarello C.A., Cerami A., Wolff S.M., Wilmore D.W. Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl. J. Med. 1988, 318:1481-1486.
222. Minghetti L. Role of inflammation in neurodegenerative diseases. Curr. Opin. Neurol. 2005, 18:315-321.
223. Mizuno T., Kawanokuchi J., Numata K., Suzumura A. Production and neuroprotective functions of fractalkine in the central nervous system. Brain Res. 2003, 979:65-70.
224. Modolell M., Corraliza I.M., Link F., Soler G., Eichmann K. Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur. J. Immunol. 1995, 25:1101-1104.
225. Moore K., Zhang Q., Murgolo N., Hosted T., Duffy R. Cloning, expression, and pharmacological characterization of the GPR120 free fatty acid receptor from cynomolgus monkey: comparison with human GPR120 splice variants. Comp. Biochem. Physiol. B. Biochem. Mol. Biol. 2009, 154:419-426.
226. Mor G., Nilsen J., Horvath T., Bechmann I., Brown S., Garcia-Segura L.M., Naftolin F. Estrogen and microglia: a regulatory system that affects the brain. J. Neurobiol. 1999, 40:484-496.
227. More S.V., Park J.-Y., Kim B.-W., Kumar H., Lim H.-W., Kang S.-M., Koppula S., Yoon S.-H., Choi D.-K. Anti-neuroinflammatory activity of a novel cannabinoid derivative by inhibiting the NF-κB signaling pathway in lipopolysaccharide-induced BV-2 microglial cells. J. Pharmacol. Sci. 2013, 121:119-130.
228. Moreira A.L., Wang J., Sarno E.N., Kaplan G. Thalidomide protects mice against LPS-induced shock. Braz. J. Med. Biol. Res. 1997, 30:1199-1207.
229. Morrison H.W., Filosa J.A. A quantitative spatiotemporal analysis of microglia morphology during ischemic stroke and reperfusion. J. Neuroinflamm. 2013, 10:4.
230. Mortier E., Advincula R., Kim L., Chmura S., Barrera J., Reizis B., Malynn B.A., Ma A. Macrophage- and dendritic-cell-derived interleukin-15 receptor alpha supports homeostasis of distinct CD8+ T cell subsets. Immunity 2009, 31:811-822.
231. Mosher K.I., Wyss-Coray T. Microglial dysfunction in brain aging and Alzheimer's disease. Biochem. Pharmacol. 2014, 88:594-604.
232. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008, 8:958-969.
233. Mou C., Liu B., Wang M., Jiang M., Han T. PGC-1-related coactivator (PRC) is an important regulator of microglia M2 polarization. J. Mol. Neurosci. 2015, 55:69-75.
234. Moussaud S., Draheim H.J. A new method to isolate microglia from adult mice and culture them for an extended period of time. J. Neurosci. Methods 2010, 187:243-253.
235. Moussaud S., Lamodière E., Savage C., Draheim H.J. Characterisation of K+ currents in the C8-B4 microglial cell line and their regulation by microglia activating stimuli. Cell. Physiol. Biochem. 2009, 24:141-152.
236. Mueller T. Structure, binding, and antagonists in the IL-4/IL-13 receptor system. Biochim. Biophys. Acta - Mol. Cell Res. 2002, 1592:237-250.
237. Müller J.M., Ziegler-Heitbrock H.W., Baeuerle P.A. Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology 1993, 187:233-256.
238. Munder M. Arginase: an emerging key player in the mammalian immune system. Br. J. Pharmacol. 2009, 158:638-651.
239. Nadeau S., Rivest S. Role of microglial-derived tumor necrosis factor in mediating CD14 transcription and nuclear factor kappa B activity in the brain during endotoxemia. J. Neurosci. 2000, 20:3456-3468.
240. Nagai A., Nakagawa E., Hatori K., Choi H.B., McLarnon J.G., Lee M.A., Kim S.U. Generation and characterization of immortalized human microglial cell lines: expression of cytokines and chemokines. Neurobiol. Dis. 2001, 8:1057-1068.
241. Nagai A., Mishima S., Ishida Y., Ishikura H., Harada T., Kobayashi S., Kim S.U. Immortalized human microglial cell line: phenotypic expression. J. Neurosci. Res. 2005, 81:342-348.
242. Neubrand V.E., Pedreño M., Caro M., Forte-Lago I., Delgado M., Gonzalez-Rey E. Mesenchymal stem cells induce the ramification of microglia via the small RhoGTPases Cdc42 and Rac1. Glia 2014, 62:1932-1942.
243. Nikodemova M., Watters J.J. Efficient isolation of live microglia with preserved phenotypes from adult mouse brain. J. Neuroinflamm. 2012, 9:147.
244. Nimmerjahn A. Two-photon imaging of microglia in the mouse cortex in vivo. Cold Spring Harb. Protoc. 2012, 5:594-603.
245. Nimmerjahn A., Kirchhoff F., Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005, 308:1314-1318.
246. Nio Y., Yamauchi T., Iwabu M., Okada-Iwabu M., Funata M., Yamaguchi M., Ueki K., Kadowaki T. Monocyte chemoattractant protein-1 (MCP-1) deficiency enhances alternatively activated M2 macrophages and ameliorates insulin resistance and fatty liver in lipoatrophic diabetic A-ZIP transgenic mice. Diabetologia 2012, 55:3350-3358.
247. Nishiyori A., Minami M., Ohtani Y., Takami S., Yamamoto J., Kawaguchi N., Kume T., Akaike A., Satoh M. Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia?. FEBS Lett. 1998, 429:167-172.
248. Noyce A.J., Bestwick J.P., Silveira-Moriyama L., Hawkes C.H., Giovannoni G., Lees A.J., Schrag A. Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann. Neurol. 2012, 72:893-901.
249. Nunan R., Sivasathiaseelan H., Khan D., Zaben M., Gray W. Microglial VPAC1R mediates a novel mechanism of neuroimmune-modulation of hippocampal precursor cells via IL-4 release. Glia 2014, 62:1313-1327.
250. O'Connell R.M., Taganov K.D., Boldin M.P., Cheng G., Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:1604-1609.
251. Odegaard J.I., Chawla A. Mechanisms of macrophage activation in obesity-induced insulin resistance. Nat. Clin. Pract. Endocrinol. Metab. 2008, 4:619-626.
252. Odegaard J.I., Ricardo-Gonzalez R.R., Goforth M.H., Morel C.R., Subramanian V., Mukundan L., Red Eagle A., Vats D., Brombacher F., Ferrante A.W., Chawla A. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 2007, 447:1116-1120.
253. Oehmichen M. Are resting and/or reactive microglia macrophages?. Immunobiology 1982, 161:246-254.
254. Oehmichen M., Huber H. Reactive microglia with membrane features of mononuclear phagocytes. J. Neuropathol. Exp. Neurol. 1976, 35:30-39.
255. Oh D.Y., Talukdar S., Bae E.J., Imamura T., Morinaga H., Fan W., Li P., Lu W.J., Watkins S.M., Olefsky J.M. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010, 142:687-698.
256. Ohsawa K., Imai Y., Nakajima K., Kohsaka S. Generation and characterization of a microglial cell line, MG5, derived from a p53 deficient mouse. Glia 1997, 298:285-298.
257. Okada H., Giezeman-Smits K.M., Tahara H., Attanucci J., Fellows W.K., Lotze M.T., Chambers W.H., Bozik M.E. Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine. Gene Ther. 1999, 6:219-226.
258. Onaivi E.S. Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain. Neuropsychobiology 2006, 54:231-246. 10.1159/000100778.
259. Onaivi E.S., Ishiguro H., Gong J.-P., Patel S., Perchuk A., Meozzi P.A., Myers L., Mora Z., Tagliaferro P., Gardner E., Brusco A., Akinshola B.E., Liu Q.-R., Hope B., Iwasaki S., Arinami T., Teasenfitz L., Uhl G.R. Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann. N. Y. Acad. Sci. 2006, 1074:514-536.
260. Ory D., Celen S., Verbruggen A., Bormans G. PET radioligands for in vivo visualization of neuroinflammation. Curr. Pharm. Des. 2014, 20:5897-5913.
261. Ouchi Y., Yoshikawa E., Sekine Y., Futatsubashi M., Kanno T., Ogusu T., Torizuka T. Microglial activation and dopamine terminal loss in early Parkinson's disease. Ann. Neurol. 2005, 57:168-175.
262. Pascual O., Ben Achour S., Rostaing P., Triller A., Bessis A. Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:E197-E205.
263. Pasparakis M., Alexopoulou L., Episkopou V., Kollias G. Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 1996, 184:1397-1411.
264. Patel A.R., Ritzel R., McCullough L.D., Liu F. Microglia and ischemic stroke: a double-edged sword. Int. J. Physiol. Pathophysiol. Pharmacol. 2013, 5:73-90.
265. Pavese N., Gerhard A., Tai Y.F., Ho A.K., Turkheimer F., Barker R.A., Brooks D.J., Piccini P. Microglial activation correlates with severity in Huntington disease: a clinical and PET study. Neurology 2006, 66:1638-1643.
266. Perego C., Fumagalli S., De Simoni M.-G. Temporal pattern of expression and colocalization of microglia/macrophage phenotype markers following brain ischemic injury in mice. J. Neuroinflamm. 2011, 8:174.
267. Pesheva P., Urschel S., Frei K., Probstmeier R. Murine microglial cells express functionally active galectin-3 in vitro. J. Neurosci. Res. 1998, 51:49-57.
268. Pfeffer K., Matsuyama T., Kündig T.M., Wakeham A., Kishihara K., Shahinian A., Wiegmann K., Ohashi P.S., Krönke M., Mak T.W. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 1993, 73:457-467.
269. Pinhal-Enfield G., Ramanathan M., Hasko G., Vogel S.N., Salzman A.L., Boons G.-J., Leibovich S.J. An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors. Am. J. Pathol. 2003, 163:711-721.
270. Pisanu A., Lecca D., Mulas G., Wardas J., Simbula G., Spiga S., Carta A.R. Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease. Neurobiol. Dis. 2014, 71:280-291.
271. Polazzi E., Monti B. Microglia and neuroprotection: from in vitro studies to therapeutic applications. Prog. Neurobiol. 2010, 92:293-315.
272. Pomeshchik Y., Kidin I., Korhonen P., Savchenko E., Jaronen M., Lehtonen S., Wojciechowski S., Kanninen K., Koistinaho J., Malm T. Interleukin-33 treatment reduces secondary injury and improves functional recovery after contusion spinal cord injury. Brain. Behav. Immun. 2015, 44:68-81.
273. Ponomarev E.D., Novikova M., Maresz K., Shriver L.P., Dittel B.N. Development of a culture system that supports adult microglial cell proliferation and maintenance in the resting state. J. Immunol. Methods 2005, 300:32-46.
274. Ponomarev E.D., Shriver L.P., Dittel B.N. CD40 expression by microglial cells is required for their completion of a two-step activation process during central nervous system autoimmune inflammation. J. Immunol. 2006, 176:1402-1410.
275. Ponomarev E.D., Veremeyko T., Barteneva N., Krichevsky A.M., Weiner H.L. MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α-PU.1 pathway. Nat. Med. 2011, 17:64-70.
276. Ponomarev E.D., Veremeyko T., Weiner H.L. MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS. Glia 2013, 61:91-103.
277. Price D.A., Martinez A., Seillier A., Koek W., Acosta Y., Fernandez E., Strong R., Lutz B., Marsicano G., Roberts J.L., Giuffrida A. WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Eur. J. Neurosci. 2009, 29:2177-2186.
278. Prinz M., Hanisch U.K. Murine microglial cells produce and respond to interleukin-18. J. Neurochem. 1999, 72:2215-2218.
279. Prinz M., Priller J. Tickets to the brain: role of CCR2 and CX3CR1 in myeloid cell entry in the CNS. J. Neuroimmunol. 2010, 224:80-84.
280. Prokop S., Heppner F.L., Goebel H.H., Stenzel W. M2 polarized macrophages and giant cells contribute to myofibrosis in neuromuscular sarcoidosis. Am. J. Pathol. 2011, 178:1279-1286.
281. Qin L., Wu X., Block M.L., Liu Y., Breese G.R., Hong J.-S., Knapp D.J., Crews F.T. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 2007, 55:453-462.
282. Raes G., Beschin A., Ghassabeh G.H., De Baetselier P. Alternatively activated macrophages in protozoan infections. Curr. Opin. Immunol. 2007, 19:454-459.
283. Raes G., De Baetselier P., Noel W., Beschin A., Brombacher F., Hassanzadeh Gh G. Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages. J. Leukoc. Biol. 2002, 71:597-602.
284. Raes G., Van den Bergh R., De Baetselier P., Ghassabeh G.H., Scotton C., Locati M., Mantovani A., Sozzani S. Arginase-1 and Ym1 are markers for murine, but not human, alternatively activated myeloid cells. J. Immunol. 2005, 174:6561. author reply 6561-6562.
285. Ransohoff R.M., Perry V.H. Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 2009, 27:119-145.
286. Rapalino O., Lazarov-Spiegler O., Agranov E., Velan G.J., Yoles E., Fraidakis M., Solomon A., Gepstein R., Katz A., Belkin M., Hadani M., Schwartz M. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat. Med. 1998, 4:814-821.
287. Renauld J.-C. Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators. Nat. Rev. Immunol. 2003, 3:667-676.
288. Renno T., Krakowski M., Piccirillo C., Lin J.Y., Owens T. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines. J. Immunol. 1995, 154:944-953.
289. Reyes J.L., Terrazas L.I. The divergent roles of alternatively activated macrophages in helminthic infections. Parasite Immunol. 2007, 29:609-619.
290. Righi M., Mori L., De Libero G., Sironi M., Biondi A., Mantovani A., Donini S.D., Ricciardi-Castagnoli P. Monokine production by microglial cell clones. Eur. J. Immunol. 1989, 19:1443-1448.
291. Rimmerman N., Ben-Hail D., Porat Z., Juknat A., Kozela E., Daniels M.P., Connelly P.S., Leishman E., Bradshaw H.B., Shoshan-Barmatz V., Vogel Z. Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death. Cell Death Dis. 2013, 4:e949.
292. Rivest S. Regulation of innate immune responses in the brain. Nat. Rev. Immunol. 2009, 9:429-439.
293. Rock R.B., Hu S., Deshpande A., Munir S., May B.J., Baker C.A., Peterson P.K., Kapur V. Transcriptional response of human microglial cells to interferon-gamma. Genes Immun. 2005, 6:712-719.
294. Rock R.B., Peterson P.K. Microglia as a pharmacological target in infectious and inflammatory diseases of the brain. J. Neuroimmune Pharmacol. 2006, 1:117-126.
295. Rogers J., Mastroeni D., Leonard B., Joyce J., Grover A. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?. Int. Rev. Neurobiol. 2007, 82:235-246.
296. Rolls A., Shechter R., London A., Segev Y., Jacob-Hirsch J., Amariglio N., Rechavi G., Schwartz M. Two faces of chondroitin sulfate proteoglycan in spinal cord repair: a role in microglia/macrophage activation. PLoS Med. 2008, 5:e171.
297. Rom S., Rom I., Passiatore G., Pacifici M., Radhakrishnan S., Del Valle L., Piña-Oviedo S., Khalili K., Eletto D., Peruzzi F. CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells. FASEB J. 2010, 24:2292-2300.
298. Ruggiero V., D'Urso C.M., Albertoni C., Campo S., Foresta P., Martelli E.A. LPS-induced serum TNF production and lethality in mice: effect of L-carnitine and some acyl-derivatives. Mediators Inflamm. 1993, 2:S43-S50.
299. Saba K., Denda-Nagai K., Irimura T. A C-type lectin MGL1/CD301a plays an anti-inflammatory role in murine experimental colitis. Am. J. Pathol. 2009, 174:144-152.
300. Sagredo O., García-Arencibia M., de Lago E., Finetti S., Decio A., Fernández-Ruiz J. Cannabinoids and neuroprotection in basal ganglia disorders. Mol. Neurobiol. 2007, 36:82-91.
301. Saijo K., Glass C.K. Microglial cell origin and phenotypes in health and disease. Nat. Rev. Immunol. 2011, 11:775-787.
302. Samii A., Etminan M., Wiens M.O., Jafari S. NSAID use and the risk of Parkinson's disease: systematic review and meta-analysis of observational studies. Drugs Aging 2009, 26:769-779.
303. Satoh J., Lee Y.B., Kim S.U. T-cell costimulatory molecules B7-1 (CD80) and B7-2 (CD86) are expressed in human microglia but not in astrocytes in culture. Brain Res. 1995, 704:92-96.
304. Sawada M., Imai F., Suzuki H., Hayakawa M. Brain-specific gene expression by immortalized microglial cell-mediated gene transfer in the mammalian brain. FEBS Lett. 1998, 433:98-101.
305. Sawano S., Suzuki T., Do M.-K.Q., Ohtsubo H., Mizunoya W., Ikeuchi Y., Tatsumi R. Supplementary immunocytochemistry of hepatocyte growth factor production in activated macrophages early in muscle regeneration. Anim. Sci. J 2015, 44:68-81.
306. Schebesch C., Kodelja V., Müller C., Hakij N., Bisson S., Orfanos C.E., Goerdt S. Alternatively activated macrophages actively inhibit proliferation of peripheral blood lymphocytes and CD4+ T cells in vitro. Immunology 1997, 92:478-486.
307. Schilling M., Besselmann M., Leonhard C., Mueller M., Ringelstein E.B., Kiefer R. Microglial activation precedes and predominates over macrophage infiltration in transient focal cerebral ischemia: a study in green fluorescent protein transgenic bone marrow chimeric mice. Exp. Neurol. 2003, 183:25-33.
308. Schwartz M. Tissue-repairing blood-derived macrophages are essential for healing of the injured spinal cord: from skin-activated macrophages to infiltrating blood-derived cells?. Brain. Behav. Immun. 2010, 24:1054-1057.
309. Sedgwick J.D., Schwender S., Imrich H., Dorries R., Butcher G.W., ter Meulen V. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:7438-7442.
310. Selenica M.-L.B., Alvarez J.A., Nash K.R., Lee D.C., Cao C., Lin X., Reid P., Mouton P.R., Morgan D., Gordon M.N. Diverse activation of microglia by chemokine (C-C motif) ligand 2 overexpression in brain. J. Neuroinflammation 2013, 10:86.
311. Shaikh S.B., Uy B., Perera A., Nicholson L.F.B. AGEs-RAGE mediated up-regulation of connexin43 in activated human microglial CHME-5 cells. Neurochem. Int. 2012, 60:640-651.
312. Shapiro H., Lutaty A., Ariel A. Macrophages, meta-inflammation, and immuno-metabolism. Sci. World J. 2011, 11:2509-2529.
313. Shechter R., London A., Varol C., Raposo C., Cusimano M., Yovel G., Rolls A., Mack M., Pluchino S., Martino G., Jung S., Schwartz M. Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med. 2009, 6:e1000113.
314. Shen Z., Lu M., Duan S., Duan S. Macrophage polarization and inflammation at the interface of cardiovascular disease and metabolism. Am. Chin. J. Med. Sci. 2011, 4:191.
315. Shin J.A., Lim S.M., Jeong S.I., Kang J.L., Park E.M. Noggin improves ischemic brain tissue repair and promotes alternative activation of microglia in mice. Brain. Behav. Immun. 2014, 40:143-154.
316. Sica A., Larghi P., Mancino A., Rubino L., Porta C., Totaro M.G., Rimoldi M., Biswas S.K., Allavena P., Mantovani A. Macrophage polarization in tumour progression. Semin. Cancer Biol. 2008, 18:349-355.
317. Sierra S., Luquin N., Rico A.J., Gómez-Bautista V., Roda E., Dopeso-Reyes I.G., Vázquez A., Martínez-Pinilla E., Labandeira-García J.L., Franco R., Lanciego J.L. Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental Parkinsonism. Brain Struct. Funct 2014, (in press).
318. Smith K.M., Pottage L., Thomas E.R., Leishman A.J., Doig T.N., Xu D., Liew F.Y., Garside P. Th1 and Th2 CD4+ T cells provide help for B cell clonal expansion and antibody synthesis in a similar manner in vivo. J. Immunol. 2000, 165:3136-3144.
319. Sobrado M., Pereira M.P., Ballesteros I., Hurtado O., Fernández-López D., Pradillo J.M., Caso J.R., Vivancos J., Nombela F., Serena J., Lizasoain I., Moro M.A. Synthesis of lipoxin A4 by 5-lipoxygenase mediates PPARgamma-dependent, neuroprotective effects of rosiglitazone in experimental stroke. J. Neurosci. 2009, 29:3875-3884.
320. Solito E., Sastre M. Microglia function in Alzheimer's disease. Front. Pharmacol. 2012, 3:14.
321. Song C., Luo L., Lei Z., Li B., Liang Z., Liu G., Li D., Zhang G., Huang B., Feng Z.-H. IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma. J. Immunol. 2008, 181:6117-6124.
322. Song E., Ouyang N., Hörbelt M., Antus B., Wang M., Exton M.S. Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. Cell. Immunol. 2000, 204:19-28.
323. Spence R.D., Wisdom A.J., Cao Y., Hill H.M., Mongerson C.R.L., Stapornkul B., Itoh N., Sofroniew M.V., Voskuhl R.R. Estrogen mediates neuroprotection and anti-inflammatory effects during EAE through ERα signaling on astrocytes but not through ERβ signaling on astrocytes or neurons. J. Neurosci. 2013, 33:10924-10933.
324. Spence S., Fitzsimons A., Boyd C.R., Kessler J., Fitzgerald D., Elliott J., Gabhann J.N., Smith S., Sica A., Hams E., Saunders S.P., Jefferies C.A., Fallon P.G., McAuley D.F., Kissenpfennig A., Johnston J.A. Suppressors of cytokine signaling 2 and 3 diametrically control macrophage polarization. Immunity 2013, 38:66-78.
325. Spera P.A., Ellison J.A., Feuerstein G.Z., Barone F.C. IL-10 reduces rat brain injury following focal stroke. Neurosci. Lett. 1998, 251:189-192.
326. Stansley B., Post J., Hensley K. A comparative review of cell culture systems for the study of microglial biology in Alzheimer's disease. J. Neuroinflamm. 2012, 9:115.
327. Starossom S.C., Mascanfroni I.D., Imitola J., Cao L., Raddassi K., Hernandez S.F., Bassil R., Croci D.O., Cerliani J.P., Delacour D., Wang Y., Elyaman W., Khoury S.J., Rabinovich G.A. Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration. Immunity 2012, 37:249-263.
328. Stein D.G. Progesterone exerts neuroprotective effects after brain injury. Brain Res. Rev. 2008, 57:386-397.
329. Stein M., Keshav S., Harris N., Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 1992, 176:287-292.
330. Stella N. Endocannabinoid signaling in microglial cells. Neuropharmacology 2009, 56(Suppl. 1):244-253.
331. Stirling D.P., Cummins K., Mishra M., Teo W., Yong V.W., Stys P. Toll-like receptor 2-mediated alternative activation of microglia is protective after spinal cord injury. Brain 2014, 137:707-723.
332. Stout R.D., Jiang C., Matta B., Tietzel I., Watkins S.K., Suttles J. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J. Immunol. 2005, 175:342-349.
333. Tan J., Town T., Mullan M. CD40-CD40L interaction in Alzheimer's disease. Curr. Opin. Pharmacol. 2002, 2:445-451.
334. Tanaka S., Ishii A., Ohtaki H., Shioda S., Yoshida T., Numazawa S. Activation of microglia induces symptoms of Parkinson's disease in wild-type, but not in IL-1 knockout mice. J. Neuroinflamm. 2013, 10:143.
335. Tanaka T., Katsuma S., Adachi T., Koshimizu T., Hirasawa A., Tsujimoto G. Free fatty acids induce cholecystokinin secretion through GPR120. Naunyn. Schmiedebergs. Arch. Pharmacol 2008, 377:523-527.
336. Tang Y., Li T., Li J., Yang J., Liu H., Zhang X.J., Le W. Jmjd3 is essential for the epigenetic modulation of microglia phenotypes in the immune pathogenesis of Parkinson's disease. Cell Death Differ. 2014, 21:369-380.
337. Tchantchou F., Tucker L.B., Fu A.H., Bluett R.J., McCabe J.T., Patel S., Zhang Y. The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury. Neuropharmacology 2014, 85:427-439.
338. Thompson W.L., Karpus W.J., Van Eldik L.J. MCP-1-deficient mice show reduced neuroinflammatory responses and increased peripheral inflammatory responses to peripheral endotoxin insult. J. Neuroinflamm. 2008, 5:35.
339. Tomioka H., Tatano Y., Maw W.W., Sano C., Kanehiro Y., Shimizu T. Characteristics of suppressor macrophages induced by mycobacterial and protozoal infections in relation to alternatively activated M2 macrophages. Clin. Dev. Immunol. 2012, 2012:635451.
340. Tönges L., Günther R., Suhr M., Jansen J., Balck A., Saal K.A., Barski E., Nientied T., Götz A.A., Koch J.C., Mueller B.K., Weishaupt J.H., Sereda M.W., Hanisch U.K., Bähr M., Lingor P. Rho kinase inhibition modulates microglia activation and improves survival in a model of amyotrophic lateral sclerosis. Glia 2014, 62:217-232.
341. Tooyama I., Kimura H., Akiyama H., McGeer P.L. Reactive microglia express class I and class II major histocompatibility complex antigens in Alzheimer's disease. Brain Res. 1990, 523:273-280.
342. Tremblay M.-È., Lowery R.L., Majewska A.K. Microglial interactions with synapses are modulated by visual experience. PLoS Biol. 2010, 8:e1000527.
343. Tureyen K., Kapadia R., Bowen K.K., Satriotomo I., Liang J., Feinstein D.L., Vemuganti R. Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents. J. Neurochem. 2007, 101:41-56.
344. Ulbrich C., Zendedel A., Habib P., Kipp M., Beyer C., Dang J. Long-term cerebral cortex protection and behavioral stabilization by gonadal steroid hormones after transient focal hypoxia. J. Steroid Biochem. Mol. Biol. 2012, 131:10-16.
345. Van Noort J.M., Bsibsi M. Toll-like receptors in the CNS: implications for neurodegeneration and repair. Prog. Brain Res. 2009, 175:139-148.
346. Varnum M.M., Ikezu T. The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer's disease brain. Arch. Immunol. Ther. Exp. (Warsz) 2012, 60:251-266.
347. Veremeyko T., Siddiqui S., Sotnikov I., Yung A., Ponomarev E.D. IL-4/IL-13-dependent and independent expression of miR-124 and its contribution to M2 phenotype of monocytic cells in normal conditions and during allergic inflammation. PLOS ONE 2013, 8:e81774.
348. Walker D.G., Link J., Lue L.-F., Dalsing-Hernandez J.E., Boyes B.E. Gene expression changes by amyloid beta peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes. J. Leukoc. Biol. 2006, 79:596-610.
349. Walker W.S., Gatewood J., Olivas E., Askew D., Havenith C.E.G. Mouse microglial cell lines differing in constitutive and interferon-γ-inducible antigen-presenting activities for naive and memory CD4+ and CD8+ T cells. J. Neuroimmunol. 1995, 63:163-174.
350. Wang H.-W., Joyce J.A. Alternative activation of tumor-associated macrophages by IL-4: priming for protumoral functions. Cell Cycle 2010, 9:4824-4835.
351. Wang X., Suzuki Y. Microglia produce IFN-gamma independently from T cells during acute toxoplasmosis in the brain. J. Interferon Cytokine Res. 2007, 27:599-605.
352. Ware C.F. The TNF receptor super family in immune regulation. Immunol. Rev. 2011, 244:5-8.
353. Webb P.J., Brooks C.G. Macrophage-like suppressor cells in rats. I. Inhibition of natural macrophage-like suppressor cells by red blood cells. Cell. Immunol. 1980, 52:370-380.
354. Webb P.J., Brooks C.G., Baldwin R.W. Macrophage-like suppressor cells in rats. II. Evidence for a quantitative rather than a qualitative change in tumour-bearer animals. Cell. Immunol. 1980, 52:381-394.
355. Weigert A., Tzieply N., von Knethen A., Johann A.M., Schmidt H., Geisslinger G., Brune B. Tumor cell apoptosis polarizes macrophages role of sphingosine-1-phosphate. Mol. Biol. Cell 2007, 18:3810-3819.
356. Weil A., Davenport H. Staining of oligodendroglia and microglia in celloidin sections. Arch Neurol. Pschiat. 1933, 30:175-178.
357. Welser-Alves J.V., Milner R. Microglia are the major source of TNF-α and TGF-β1 in postnatal glial cultures; regulation by cytokines, lipopolysaccharide, and vitronectin. Neurochem. Int. 2013, 63:47-53.
358. Wen A.Y., Sakamoto K.M., Miller L.S. The role of the transcription factor CREB in immune function. J. Immunol. 2010, 185:6413-6419.
359. Wilms H., Zecca L., Rosenstiel P., Sievers J., Deuschl G., Lucius R. Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications. Curr. Pharm. Des. 2007, 13:1925-1928.
360. Wood G.W., Gollahon K.A., Tilzer S.A., Vats T., Morantz R.A. The failure of microglia in normal brain to exhibit mononuclear phagocyte markers. J. Neuropathol. Exp. Neurol. 1979, 38:369-376.
361. Wolf Y., Yona S., Kim K.-W., Jung S. Microglia, seen from the CX3CR1 angle. Front. Cell. Neurosci. 2013, 7:26.
362. Wu H.-Y., Goble K., Mecha M., Wang C.-C., Huang C.-H., Guaza C., Jan T.-R. Cannabidiol-induced apoptosis in murine microglial cells through lipid raft. Glia 2012, 60:1182-1190.
363. Yang M.-S., Park E.J., Sohn S., Kwon H.J., Shin W.-H., Pyo H.K., Jin B., Choi K.S., Jou I., Joe E.-H. Interleukin-13 and -4 induce death of activated microglia. Glia 2002, 38:273-280.
364. Yao L., Kan E.M., Kaur C., Dheen S.T., Hao A., Lu J., Ling E.-A. Notch-1 signaling regulates microglia activation via NF-κB pathway after hypoxic exposure in vivo and in vitro. PLOS ONE 2013, 8:e78439.
365. Yenari M.A., Giffard R.G. Ischemic vulnerability of primary murine microglial cultures. Neurosci. Lett. 2001, 298:5-8.
366. Yiangou Y., Facer P., Durrenberger P., Chessell I.P., Naylor A., Bountra C., Banati R.R., Anand P. COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurol. 2006, 6:12.
367. Yu J.S., Wei M.X., Chiocca E.A., Martuza R.L., Tepper R.I. Treatment of glioma by engineered interleukin 4-secreting cells. Cancer Res. 1993, 53:3125-3128.
368. Zanier E.R., Pischiutta F., Riganti L., Marchesi F., Turola E., Fumagalli S., Perego C., Parotto E., Vinci P., Veglianese P., D'Amico G., Verderio C., De Simoni M.-G. Bone marrow mesenchymal stromal cells drive protective M2 microglia polarization after brain trauma. Neurotherapeutics 2014, 11:679-695.
369. Zarruk J.G., Fernández-López D., García-Yébenes I., García-Gutiérrez M.S., Vivancos J., Nombela F., Torres M., Burguete M.C., Manzanares J., Lizasoain I., Moro M.A. Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection. Stroke 2012, 43:211-219.
370. Zhang H., Li Y., Yu J., Guo M., Meng J., Liu C., Xie Y., Feng L., Xiao B., Ma C. Rho kinase inhibitor fasudil regulates microglia polarization and function. Neuroimmunomodulation 2013, 20:313-322.
371. Zhang L., Chawla A. Role of PPARgamma in macrophage biology and atherosclerosis. Trends Endocrinol. Metab. 2004, 15:500-505.
372. Zhang W., Wang T., Pei Z., Miller D.S., Wu X., Block M.L., Wilson B., Zhang W., Zhou Y., Hong J.-S., Zhang J. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease. FASEB J. 2005, 19:533-542.
373. Zhang Z., Zhang Z.-Y., Schluesener H.J. Compound A, a plant origin ligand of glucocorticoid receptors, increases regulatory T cells and M2 macrophages to attenuate experimental autoimmune neuritis with reduced side effects. J. Immunol. 2009, 183:3081-3091.
374. Zhang Z., Zhang Z.-Y., Wu Y., Schluesener H.J. Lesional accumulation of CD163+ macrophages/microglia in rat traumatic brain injury. Brain Res. 2012, 1461:102-110.
375. Zheng X., Zheng W., Liu S., Patel H.M., Xia X., Ouyang H., Levitt R.C., Candiotti K.A., Hao S. Crosstalk between JNK and NF-(B in the KDO2-mediated production of TNFα in HAPI cells. Cell. Mol. Neurobiol. 2012, 32:1375-1383.
376. Zhou D., Huang C., Lin Z., Zhan S., Kong L., Fang C., Li J. Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways. Cell. Signal. 2014, 26:192-197.
377. Zhou H., Andonegui G., Wong C.H.Y., Kubes P. Role of endothelial TLR4 for neutrophil recruitment into central nervous system microvessels in systemic inflammation. J. Immunol. 2009, 183:5244-5250.
378. Zhou W., Cayabyab F.S., Pennefather P.S., Schlichter L.C., DeCoursey T.E. HERG-like K+ channels in microglia. J. Gen. Physiol. 1998, 111:781-794.
379. Zhou X., Spittau B., Krieglstein K. TGFβ signalling plays an important role in IL4-induced alternative activation of microglia. J. Neuroinflamm. 2012, 9:210.
380. Zhu L., Lu J., Tay S.S.W., Jiang H., He B.P. Induced NG2 expressing microglia in the facial motor nucleus after facial nerve axotomy. Neuroscience 2010, 166:842-851.
381. Zimmermann J., Krauthausen M., Hofer M.J., Heneka M.T., Campbell I.L., Müller M. CNS-targeted production of IL-17A induces glial activation, microvascular pathology and enhances the neuroinflammatory response to systemic endotoxemia. PLOS ONE 2013, 8:e57307.
382. Zlokovic B.V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008, 57:178-201.
383. Zujovic V., Benavides J., Vige X., Carter C., Taupin V. Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation. Glia 2000, 29:305-315.